BLUEFIN CAPITAL MANAGEMENT, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
BLUEFIN CAPITAL MANAGEMENT, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$234
-96.1%
46,7000.0%0.00%
-100.0%
Q3 2022$6,000
-87.2%
46,7000.0%0.00%
-80.0%
Q2 2022$47,000
-42.0%
46,7000.0%0.01%
-28.6%
Q1 2022$81,000
-78.7%
46,7000.0%0.01%
-74.1%
Q4 2021$381,000
-11.8%
46,700
-0.6%
0.03%
-37.2%
Q3 2021$432,000
+195.9%
47,000
-2.1%
0.04%
+377.8%
Q2 2021$146,00048,0000.01%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders